Anaesthetic management in patients suspected of, or at risk of, having Creutzfeldt-Jakob disease

British Journal of Anaesthesia

Volumn 80, Issue 4, 1998, Pages 516-518

  Hernandez Palazon J ^a   Martinez Lage J F ^a   Tortosa, J A ^a,b   Garcia Cayuela J M ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^b NONE   (Spain)

Author keywords

Complications, Creutzfeldt Jakob disease; Hormones, growth

Indexed keywords

ANESTHETIC AGENT; FENTANYL; HUMAN GROWTH HORMONE; ISOFLURANE; THIOPENTAL; VECURONIUM;

ADULT; ANESTHESIA; ARTICLE; BRAIN GRAFT; CASE REPORT; CREUTZFELDT JAKOB DISEASE; DURA MATER; HIGH RISK PATIENT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL;

EID: 2642702618     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/80.4.516     Document Type: Article

References (13)

1. Brown P, Gibbs C jr, Rodgers-Johnston P, Asher DM, Sulima MP, Bacote A, Golfarb LG, Gajdusek DC. Human spongiform encephalopathies: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Annals of Neurology 1994; 35: 513-519.
2. Prusiner SB. Prions and neurodegenerative diseases. New England Journal of Medicine 1987; 317: 1571-1581.
3. Brown P, Preece MA, Will RG. "Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet 1992; 340: 24-27.
4. Martinez-Lage JF, Poza M, Sola J, Tortosa JG, Brown P, Cervenáková L, Esteban JA, Mendoza A. Accidental transmission of Creutzfeldt-Jakob disease by dural cadaveric grafts. Journal of Neurology, Neurosurgery and Psychiatry 1994; 57: 1091-1094.
5. Brown P, Cervenáková L, Goldfarb LG, McCombie WR, Rubenstein R, Will RG, Pocchiari M, Martinez-Lage JF, Scalici C, Massullo C, Graupera G, Ligan J, Gajdusek DC. Iatrogenic Creutzfeldt-Jakob disease: an example of the interplay between ancient genes and modern medicine. Neurology 1994; 44: 291-293.
6. Billete de Villemeur T, Agid Y. La maladie de Creutzfeldt-Jakob iatrogène. Quelles sont las précautions à prendre pour prevenir la contamination neurochirurgicale? Neurochirurgie 1995; 41: 1-2.
7. Thadani V, Penar PL, Partington J, Kalb R, Janssen R, Schonberger LB, Rabkin CS, Prichard JW. Creutzfeldt-Jakob disease probably acquired from a cadaveric dura mater graft. Case report. Journal of Neurosurgery 1988; 69: 766-769.
8. Esmonde T, Lueck CJ, Symon L, Duchen LW, Will RG. Creutzfeldt-Jakob disease and lyophilised dura mater grafts: report of two cases. Journal of Neurology, Neurosurgery and Psychiatry 1993; 56: 999-1000.
9. Berger JR, David NJ. Creutzfeldt-Jakob disease in a physician: a review of the disease in health care workers. Neurology 1993; 43: 205-206.
10. MacMurdo SD, Jakymec AJ, Bleyaert AL. Precautions in the anesthetic management of a patient with Creutzfeldt-Jakob disease. Anesthesiology 1984; 60: 590-592.
11. Holmes SJ, Ironside JW, Shalet SM. Neurosurgery in a patient with Creutzfeldt-Jakob disease after pituitary derived growth hormone in childhood. Journal of Neurology, Neurosurgery and Psychiatry 1996; 60: 333-335.
12. Wight A, Metters JS. Neuro and ophthalmic surgery procedures on patients with, or suspected to have, or at risk of developing Creutzfeldt-Jakob disease (CJD), or Gerstmann-Straussler-Scheinker syndrome (GSS). Journal of Public Health Medicine 1993; 15: 209-210.
13. Martinez-Lage JF, Poza M. Iatrogenic Creutzfeldt-Jakob disease acquired after neurosurgery and dura mater grafts. In: Court L, Dodet B, eds. Transmissible Subacute Spongiform Encephalopathies: Prion Diseases. Paris: Elsevier, 1996; 459-464.